Acute rejection may have decrensed in relative importance, but accelerated obstructive vascular disease (sometimes referred 10 as chronic rejection) her become a major caw of po\t!ransplantation death (2). The prevalence of this problem is high: some investigator> (3) estimate that >50% ofall palients undergomg cardiac transplantation who survive 23 years have obrwuctivc vascular disease. Although multiple faclors may play a role in this process. one OS the mosl imporlant seems IO bc an altered immune environment: cla,sii cardiovascular risk factors are possibly less importan1 14-6). Although the relative importance of hyperlipidemia in tranrplantation.arsociated atherosclerosis is controversial, it is not unreasonable to suspect that increased blood levels of atherogenic particles will act synergistically with immune factors IO accelerate development of coronary artery disease (5).
tfrom 119 + 7 lo 138 I 7 mddk P < 0.02). Awlipoeratein A-l and B-100 nlw increased, bu~lip&atein(aj d&eased from Il.7 f t.7 lo 6.9 f 1.1 mg!dl; p 5 O.OW) afler transplantation.
Allhnugh lotat cholesterol. triglycerides, LDL cholesterol, apolipmiein A-t and B-100 increased dramalically ~lfier cardiac transplantation, so did HDL cholesterol, thereby keeping the LDLiHDL cholesterol rat10 cdnstant. The Previous reports ( 
